Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study.

ABSTRACT:

Background

In the elderly, impaired cognition may weaken medication adherence and compromise treatment for cardiovascular disease (CVD).

Aim

We examined risk factors for medication adherence and the relationship between adherence and levels of CVD risk factors among older participants with hypertension, dyslipidaemia and diabetes in the Framingham Heart Study.

Methods

The four-item Morisky Medication Adherence Scale was administered to 1559 participants, median age 70 years, 53% women. We created an adherence score, ranging from 0 to 4, with low adherence defined as a score ≥2. CVD risk factors were assessed using standard protocols. Cognition was measured using the Mini-Mental State Examination (MMSE) and depressive symptoms were measured using the Center for Epidemi

SUBMITTER: Hennein R 

PROVIDER: S-EPMC5889324 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature